"Designing Growth Strategies is in our DNA"

Leukemia Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Type of Leukemia (Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML)), By Treatment Type (Chemotherapy, Targeted Therapy), By Route of Administration (Oral Mode and Injectable Mode), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI104754

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Pipeline Analysis, Key Players
    2. Prevalence of Leukemia, Key Countries, 2019
    3. Key Industry Developments (Mergers, Acquisition, etc.)
    4. Impact of Covid-19 on the Leukemia Therapeutics Market
  5. Global Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis, Insights and Forecast – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis – By Country/Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis – By Country/Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Latin America Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis – By Country/Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Type of Leukemia
      1. Chronic Myeloid Leukemia (CML)
      2. Chronic Lymphocytic Leukemia (CLL)
      3. Acute Lymphocytic Leukemia (ALL)
      4. Acute Myeloid Leukemia (AML)
      5. Others
    3. Market Analysis – By Treatment Type
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
      4. Others
    4. Market Analysis – By Route of Administration
      1. Injectable Mode
      2. Oral Mode
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    6. Market Analysis – By Country/Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Novartis
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Sanofi/ Genzyme Corporation
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Lupin Ltd.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Amgen Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. AbbVie
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Bristol-Myers Squibb
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. F. Hoffmann-La Roche
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Takeda Pharmaceutical Co Ltd
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Sanofi/ Genzyme Corporation
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
Read Less

Figure 1:  Global Leukemia Therapeutics Market Revenue Breakdown (USD billion, %) by Region, 2016 & 2027

Figure 2:  Global Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2016 & 2027

Figure 3:  Global Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2016 & 2027

Figure 4:  Global Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2016 & 2027

Figure 5:  Global Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2016 & 2027

Figure 6:  Global Leukemia Therapeutics Market Value (USD billion), by Region, 2016 & 2027

Figure 7:  North America Leukemia Therapeutics Market Value (USD billion), by Type of Leukemia, 2016 & 2027

Figure 8:  North America Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2019

Figure 9:  North America Leukemia Therapeutics Market Value (USD billion), by Treatment Type, 2016 & 2027

Figure 10:  North America Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2019

Figure 11:  North America Leukemia Therapeutics Market Value (USD billion), by Route of Administration, 2016 & 2027

Figure 12:  North America Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2019

Figure 13:  North America Leukemia Therapeutics Market Value (USD billion), by Distribution Channel, 2016 & 2027

Figure 14:  North America Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 15:  North America Leukemia Therapeutics Market Value (USD billion), By Country, 2016 & 2027

Figure 16:  North America Leukemia Therapeutics Market Value Share (%), By Country, 2019

Figure 17:  Europe Leukemia Therapeutics Market Value (USD billion), by Type of Leukemia, 2016 & 2027

Figure 18:  Europe Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2019

Figure 19:  Europe Leukemia Therapeutics Market Value (USD billion), by Treatment Type, 2016 & 2027

Figure 20:  Europe Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2019

Figure 21:  Europe Leukemia Therapeutics Market Value (USD billion), by Route of Administration, 2016 & 2027

Figure 22:  Europe Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2019

Figure 23:  Europe Leukemia Therapeutics Market Value (USD billion), by Distribution Channel, 2016 & 2027

Figure 24:  Europe Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 25:  Europe Leukemia Therapeutics Market Value (USD billion), By Country/ Sub-region, 2016 & 2027

Figure 26:  Europe Leukemia Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 27:  Asia Pacific Leukemia Therapeutics Market Value (USD billion), by Type of Leukemia, 2016 & 2027

Figure 28:  Asia Pacific Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2019

Figure 29:  Asia Pacific Leukemia Therapeutics Market Value (USD billion), by Treatment Type, 2016 & 2027

Figure 30:  Asia Pacific Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2019

Figure 31:  Asia Pacific Leukemia Therapeutics Market Value (USD billion), by Route of Administration, 2016 & 2027

Figure 32:  Asia Pacific Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2019

Figure 33:  Asia Pacific Leukemia Therapeutics Market Value (USD billion), by Distribution Channel, 2016 & 2027

Figure 34:  Asia Pacific Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 35:  Asia Pacific Leukemia Therapeutics Market Value (USD billion), By Country/ Sub-region, 2016 & 2027

Figure 36:  Asia Pacific Leukemia Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 37:  Latin America Leukemia Therapeutics Market Value (USD billion), by Type of Leukemia, 2016 & 2027

Figure 38:  Latin America Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2019

Figure 39:  Latin America Leukemia Therapeutics Market Value (USD billion), by Treatment Type, 2016 & 2027

Figure 40:  Latin America Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2019

Figure 41:  Latin America Leukemia Therapeutics Market Value (USD billion), by Route of Administration, 2016 & 2027

Figure 42:  Latin America Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2019

Figure 43:  Latin America Leukemia Therapeutics Market Value (USD billion), by Distribution Channel, 2016 & 2027

Figure 44:  Latin America Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 45:  Latin America Leukemia Therapeutics Market Value (USD billion), By Country/ Sub-region, 2016 & 2027

Figure 46:  Latin America Leukemia Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 47:  Middle East & Africa Leukemia Therapeutics Market Value (USD billion), by Type of Leukemia, 2016 & 2027

Figure 48:  Middle East & Africa Leukemia Therapeutics Market Value Share (%), by Type of Leukemia, 2019

Figure 49:  Middle East & Africa Leukemia Therapeutics Market Value (USD billion), by Treatment Type, 2016 & 2027

Figure 50:  Middle East & Africa Leukemia Therapeutics Market Value Share (%), by Treatment Type, 2019

Figure 51:  Middle East & Africa Leukemia Therapeutics Market Value (USD billion), by Route of Administration, 2016 & 2027

Figure 52:  Middle East & Africa Leukemia Therapeutics Market Value Share (%), by Route of Administration, 2019

Figure 53:  Middle East & Africa Leukemia Therapeutics Market Value (USD billion), by Distribution Channel, 2016 & 2027

Figure 54:  Middle East & Africa Leukemia Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 55:  Middle East & Africa Leukemia Therapeutics Market Value (USD billion), By Country/ Sub-region, 2016 & 2027

Figure 56:  Middle East & Africa Leukemia Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 57:  Global Leukemia Therapeutics Market Share (%), By Company, 2019

Table 1:  Global Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 2:  Global Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 3:  Global Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 4:  Global Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 5:  Global Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Region, 2016-2027

Table 6:  North America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 7:  North America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 8:  North America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 9:  North America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 10:  North America Leukemia Therapeutics Market Revenue (USD billion) Forecast, By Country, 2016-2027

Table 11:  Europe Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 12:  Europe Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 13:  Europe Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 14:  Europe Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 15:  Europe Leukemia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Asia Pacific Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 17:  Asia Pacific Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 18:  Asia Pacific Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 19:  Asia Pacific Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 20:  Asia Pacific Leukemia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Latin America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 22:  Latin America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 23:  Latin America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 24:  Latin America Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 25:  Latin America Leukemia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

Table 26:  Middle East & Africa Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Type of Leukemia, 2016-2027

Table 27:  Middle East & Africa Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Treatment Type, 2016-2027

Table 28:  Middle East & Africa Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2016-2027

Table 29:  Middle East & Africa Leukemia Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2016-2027

Table 30:  Middle East & Africa Leukemia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2016-2027

Leukemia Therapeutics Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase